Results of mechanistic 196 experiments suggested that DUXAP10 motivated ESCC progression through recruiting enhancer of zeste homolog 2 (EZH2) to the promoter of p21 [126]. The gene discussed is EZH2; the disease is esophageal squamous cell carcinoma.